Moben Mirza, MD, FACS

“IP Unplugged” — Coming Soon 🎙️ - Explore the science, skills and stories beyond Interventional Pulmonology. A first-of-its-kind podcast bringing real conversations, real experiences, and real learnings from the world of Interventional Pulmonology — unfiltered and unplugged. Featuring global experts discussing cutting-edge technology, real-world challenges, and insights with a personal touch. Stay tuned for trailers, clips, and the pilot episode with Dr Mohammed Munavvar, Professor and Head of Department, Lancashire Teaching Hospitals, Preston, United Kingdom. #IPUnplugged #InterventionalPulmonology #PodcastLaunch #Pulmonology #MedicalPodcast Anish Goel Sandeep Singh Olympus Corporation

55

4 Comments

Can #AI Assessment of Non-Calcified Plaque Volume Enhance CT Assessment of MACE Risk Beyond CAC Scoring? https://lnkd.in/ePWyisdG American College of Radiology ARRS (American Roentgen Ray Society) Radiological Society of North America (RSNA) Society of Cardiovascular Computed Tomography Tyler Coombes Cleerly James Min, MD #radiology #RadRes #CTRad

1

Researchers at University Hospitals and Case Western Reserve University including Zachary Strumpf, MD, Susheel Patil, MD, Kingman Strohl, MD, Frank Jacono, MD, Farhad Kaffashi, and Kenneth A. Loparo, PhD are developing a machine learning model tool to screen sleep-disordered breathing in hospitalized patients. This approach has the potential to improve early diagnosis and better coordinate treatment pathways for high‑risk patients by identifying breathing abnormalities sooner. Read more about how this innovation is paving the way for “smart” monitors that offer a scalable, noninvasive method to alert providers to breathing issues while patients are still hospitalized: https://lnkd.in/eCQ-cNWY

6

Demystifying the Path: The Patient Journey in Radiation Therapy Radiation therapy is a cornerstone of modern cancer treatment, saving and improving countless lives. Yet, for many patients and their families, the process can seem complex and daunting. At the Pakistan Society of Radiation Therapists (PSORT), we believe that knowledge is empowering. By understanding the journey, we can better support those undergoing treatment. Let’s break down the typical path a patient takes, from initial consultation to follow-up care. Here is a closer look at each key step: Consultation: The journey begins with a meeting with a radiation oncologist. They review the patient's medical history, pathology reports, and imaging to determine if radiation therapy is the right course of action. This is a time for questions and open discussion. Simulation (CT Sim): This is a crucial planning session, not a treatment. Using a dedicated CT scanner, the team captures detailed images of the body to pinpoint the exact location of the tumor and surrounding healthy tissues. Immobilization devices, like masks or molds, might be custom-made to ensure precise and reproducible positioning for every treatment. Treatment Planning: Behind the scenes, a highly skilled team of medical physicists and dosimetrists uses the simulation data to design a customized treatment plan. This complex process involves calculating the optimal angles and intensities of radiation beams to maximize the dose to the tumor while sparing as much healthy tissue as possible. Treatment Delivery: This is the phase where the plan is put into action. Over a course of several weeks, the patient attends daily sessions where radiation therapists administer the prescribed dose using sophisticated machines like linear accelerators. Each session is painless and typically lasts only a few minutes. Follow-Up Care: The journey doesn't end with the final treatment session. Regular follow-up appointments with the radiation oncologist are essential to monitor the tumor's response to treatment and manage any short-term or long-term side effects. By shedding light on this process, we hope to alleviate anxiety and foster a better understanding of the vital role radiation therapy plays in comprehensive cancer care. Have questions about any step of this journey? Leave a comment below, and let's discuss! #PSORT #RadiationTherapy #PatientEducation #CancerCare #MedicalPhysics #OncologyPakistan #HealthAwareness #ELEKTA #ASRT #ESTRO #AMSTRO # MR-Linac CONSORTIUM

6

1 Comment

Mayo Clinic researchers have developed an artificial intelligence system that can detect surgical site infections from photos submitted by patients. “This work lays the foundation for AI-assisted postoperative wound care, which can transform how postoperative patients are monitored,” said study first author Dr. Hala Muaddi (pictured here in surgery) Julia Rock-Torcivia has the details at the Medical Design & Outsourcing link in the comments below.

7

1 Comment

Cardiology Intelligence Brief — March 1, 2026 Dr. Emre Ertürk | Cardiologist A review of recent ESC, ACC, and AHA communications and affiliated journal updates over the past 72 hours confirms no new guideline publications or practice-changing randomized trial releases. As March begins, the cardiology agenda remains centered on risk execution and clinical consistency rather than therapeutic redefinition. Current clinical focal points Acute coronary syndromes — secondary prevention reinforcement Post-discharge continuity remains central. Emphasis continues on dual antiplatelet adherence where indicated, high-intensity lipid therapy persistence, and early outpatient reassessment within structured care pathways. Chronic coronary disease — ischemia-guided reassessment Functional capacity changes and objective ischemia burden remain decisive in prompting further evaluation. Anatomical descriptors alone do not determine risk trajectory. Heart failure — outpatient stability metrics In stable HFrEF and HFpEF cohorts, attention remains on maintaining GDMT intensity, monitoring renal function during titration, and identifying early congestion signals before clinical decompensation. Hypertension — confirmation before escalation Out-of-office BP verification, nocturnal pattern analysis, and adherence assessment remain prerequisites before labeling resistant hypertension or modifying therapy. Atrial fibrillation — anticoagulation continuity and risk alignment Stroke prevention strategy remains anchored to thromboembolic risk stratification. Persistence of anticoagulation and renal-adjusted dosing remain core priorities. No new interventional directives have emerged. Evidence cycle context Early March begins without new society mandates. Communication remains operational and implementation-focused rather than directive. Clinical takeaway Current cardiology practice emphasizes: • disciplined secondary prevention • ischemia-guided coronary reassessment • sustained HF optimization • structured BP validation • risk-anchored AF management Therapeutic thresholds remain stable; execution quality remains decisive. Dr. Emre Ertürk Cardiology Specialist 🌐 www.emreerturk.com.tr ☎️ 444 5 433 📍 Feneryolu Bağdat Caddesi No:191/A 34730 Kadıköy / İstanbul #Cardiology #ClinicalUpdates #cardiologist

45

1 Comment

https://lnkd.in/g4YFXX_u Thank you to Society of Interventional Radiology for the opportunity to interview my friend and colleague Dr. Dana Dunleavy, MD on the Kinked Wire Podcast. In Episode 65 Dr. Dunleavy and I chat about the challenges and importance of practicing Interventional Radiology in small and rural communities, like those served by Gundersen Health System in La Crosse Wisconsin. These communities are facing a critical shortage of access to specialty IR care. "Not everyone in an underserved hospital is going to want to do all advanced procedures. And so fortunately, one of the things we have been able to do, as Dr. Ian Wilson coined, is we work where we're needed and live where we want to." - J. Dana Dunleavy, MD Read more about small and rural practice models: https://lnkd.in/gkjh8hut https://lnkd.in/gNVb6tsD https://lnkd.in/gmi8Pmh5

25

Collaborating with expert Dermatologist Dr. Sancy Leachman on developing the "Skin Cancer Basics for the Advanced Practice Provider: Practical Steps to Improve Patient Care" was truly fulfilling. With Dr. Leachman's extensive experience in Dermatology, we crafted an educational resource tailored for PAs and NPs who may have limited exposure to diagnosing, referring, and treating patients with atypical pigmented lesions and melanoma. This concise introduction to the world of melanoma holds significant importance for healthcare providers across various practice environments, offering essential insights for improved patient care. Special thanks to Lyerka Miller, PhD, CHCP for her exceptional organization of this initiative! #melanoma #dermatology #dermpa #pigmentedlesions https://lnkd.in/gKU7BVWD

43

2 Comments

Mayo's Dr. Ahmad Nassr and colleagues are leading advances in robotics, AI, and motion-preserving implants to transform how we treat back and neck conditions. Learn how innovations in spine care are enabling more personalized treatment and faster recovery for patients: https://lnkd.in/esiAF2dP

214

9 Comments

Large Study of Medicare Patients with DFUs Reveals Benefits of DHACM in Reducing Amputations and Long-Term Health-Care Costs https://lnkd.in/gYRZ2qAB

12

1 Comment

🔴 LIVE from CSIMS-California Society of Industrial Medicine and Surgery: Dr. Sanjay Ghosh, MD, FAANS, FACS breaking down spinal injury mechanics at CSIMS. USC neurosurgery. House Ear Clinic skull base fellowship. Created San Diego's only multidisciplinary skull base team. His demonstration: How rear-impact collisions create the perfect conditions for disc herniation. Head flexion + vertex impact = catastrophic spine injury. 'If you wanted to herniate someone's disc, that's exactly how you'd do it.' The clinical evaluation pathway he's outlining - mechanism of injury, completeness assessment, spinal shock, clinical stability - determines surgical versus conservative management. These decisions, made in the first hours after injury, shape permanent outcomes. In occupational medicine, we see these patterns in industrial vehicle accidents, falls from height, struck-by incidents. Understanding the biomechanics helps predict injury severity and guide return-to-work planning. Currently live at Catastrophic Injuries session, Commodore A. #CSIMS2025 #Neurosurgery #SpinalTrauma #Biomechanics #CatastrophicInjury"

9

What Your Asthma Score Consistently Misses The ACQ-5 is a reliable tool but it misses more than most clinicians realize. The ACQ-5 has earned its place in asthma management. Five questions, a practical symptom burden score, a quick read on disease control. But a study published in BMC Pulmonary Medicine raises a question worth sitting with: what exactly is the ACQ-5 capturing — and what is it leaving behind? Retrospective cross-sectional analysis of 171 treatment-naïve adults with uncontrolled asthma at a primary care respiratory clinic in Japan. They assessed airflow limitation patterns — normal lung function, isolated small airway dysfunction (iSAD), and overt airflow limitation (AFL) — alongside T2 inflammatory phenotype using spirometry and biomarkers. Where the ACQ-5 performed well was expected. Higher scores were strongly associated with overt airflow limitation, correlating moderately with FEV1 and FEF25-75 percent predicted. When a patient's airways are obstructed and symptomatic, the ACQ-5 reflects it. Gaps are where the clinical weight lies. About 48% of patients had T2-high inflammation — the phenotype most relevant to biologic therapy eligibility. The ACQ-5 was a poor discriminator for this group. It was equally limited in detecting isolated small airway dysfunction. In a treatment landscape where biologics are available but consistently underutilized, missing T2-high phenotype at initial assessment has real consequences. A patient with high symptom burden and undetected eosinophilic inflammation may receive escalating step therapy when a targeted biologic would be the more appropriate choice. Authors frame it that the ACQ-5 is a complementary tool, not a comprehensive one. Integrating point-of-care technologies — FeNO measurement, impulse oscillometry, peripheral eosinophil counts — into primary care evaluations could meaningfully close this gap for the patients who need it most. KEY TAKEAWAYS Takeaway 1 — ACQ-5 reliably identifies overt airflow limitation but is a poor discriminator for T2-high phenotype and isolated small airway dysfunction — findings that directly shape biologic therapy eligibility. Takeaway 2 — Nearly half of treatment-naïve uncontrolled asthma patients in this cohort had T2-high inflammation, yet symptom scores alone failed to identify most of them. Phenotyping must accompany symptom assessment. Takeaway 3 — Point-of-care tools such as FeNO testing and advanced spirometry should be integrated into primary care evaluations for uncontrolled asthma to bridge the gap between symptom burden and underlying airway biology. #Asthma #RespiratoryTherapy #AirwayInflammation #ClinicalResearch #PulmonaryMedicine SOURCE: Stong C. "ACQ-5 Identifies Overt Airflow Limitation in Treatment-Naïve Uncontrolled Asthma." Pulmonology Advisor. March 23, 2026. Study published in BMC Pulmonary Medicine.

25

1 Comment

In the August issue of Advances in Radiation Oncology, a study by researchers at UT Southwestern Medical Center is the first to compare a 5-fraction hypofractionated regimen delivered on Elekta Unity for glioblastoma with standard 15- and 30-fraction schedules. Their findings show that patients receiving five fractions traveled an average of 220 miles, saving up to 1,100 miles compared to those receiving 30 fractions, suggesting that MRgRT with Unity may reduce treatment burden and support quality of life without compromising efficacy. Read the article ➡️ https://bit.ly/45PqcnS.

79

1 Comment

Real Outcomes with the University of Chicago. ✨ The University of Chicago Center for CME leveraged ACCME’s Commendation Criteria to showcase how outcomes-focused CME can strengthen communities via: ✔️A multidisciplinary hip fracture program that reduced hospital length of stay and strengthened coordination of care throughout patients' recovery. ✔️A diabetes management initiative that achieved over a 10% reduction in patients' hemoglobin A1C levels. 💬 “Integrating the Commendation Criteria into our work empowered our team and made patient care better.” — Tom Weber, EdM, CHCP ➡️ Read more: https://lnkd.in/gx6gsi-p

26

Jonathan Chen, MD, PhD, director of AI in medical education at Stanford Medicine, has a few tricks up his sleeve when it comes to explaining how AI is reshaping medicine and patient care. Cutting through the smoke and mirrors, Chen separates anxiety from optimism around the hype. 

286

3 Comments

ICYMI, my two-part series on the past, present, and future state of PE-backed Orthopedic MSOs: Part 1 (Past and Present) ➡️ https://lnkd.in/er7-2-Sn Part 2 (Future) ➡️ https://lnkd.in/eVJWsrYM One additional thought I didn't cover: Some of these platforms are struggling because each side expected the other to do the heavy lifting. Surgeons thought PE sponsors would bring operational excellence and economy of scale efficiency allowing them to work smarter not harder. Rollup math and spreadsheet black magic would create value and make a favorable exit in the expected timeline a near certainty. They just needed to keep plugging for a few years. But the benefits of that business acumen never materialized for many. Meanwhile, PE sponsors assumed docs would be motivated to grow their practices and support the platform to reach the desired outcome. A rising tide would lift all boats. But the incentives never quite aligned. Older surgeons got a payout and were content to coast. Mid-career surgeons were already grinding at or near max capacity. Young surgeons didn't have enough skin in the game. The longer hold periods get, the more motivation wanes. The disconnect between the MSO and the physicians widens. Model projections go from aspirational to fantastical. The math problem becomes a people problem. Success always hinged on change management and change management hinges on understanding each side's motivations. Trust and buy-in are built on the ground, not at arm's length.

42

13 Comments

Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive.

24

AI is rapidly transforming point-of-care ultrasound (POCUS) from a purely operator-dependent skill into a powerful, AI-augmented bedside tool. In this narrative review, authors describe how AI enhances image acquisition (real-time probe guidance for novices), interpretation (automated EF estimation, pneumothorax detection, DVT screening, optic nerve sheath measurements), task automation (VTI, IVC, and hemodynamic calculations), procedural guidance, and even program-level quality assurance and reporting . While early data show promising accuracy and workflow efficiencies, particularly in critical care settings- the authors emphasize the need for external validation, diverse datasets, safeguards against data drift, and continued clinician oversight. The future of POCUS is not AI replacing intensivists, but AI functioning as a precision assistant, hence - democratizing ultrasound expertise while keeping clinical reasoning firmly in the clinicians hands . #POCUS #MedEd #LifeLongLearning

10

Professor Abdelazeem Eldawlatly, MD, FRCA, is a distinguished consultant anesthesiologist and an internationally recognized academic leader in anesthesiology and perioperative medicine. He is known for his significant contributions to airway management, obstetric anesthesia, and the advancement of anesthesia education across the Middle East and beyond. As a Professor of Anesthesiology, he has played a pivotal role in shaping postgraduate training programs and fostering academic excellence. His commitment to developing modern anesthesia practice emphasizes patient safety, evidence-based care, and multidisciplinary collaboration. Professor Eldawlatly is a founding figure and former president of a prominent organization, leading numerous national and international initiatives aimed at improving standards of anesthetic care and professional development. His leadership has been crucial in organizing major scientific conferences and building connections between regional and global anesthesiology communities. An accomplished researcher and educator, he has authored and co-authored numerous peer-reviewed publications and is frequently invited to speak at international conferences. His influential work in airway management has contributed to clinical practice guidelines and advanced strategies for managing difficult airways in various clinical settings. Through his dedication to education, mentorship, and innovation in clinical practice, Professor Eldawlatly continues to inspire generations of anesthesiologists, leaving a lasting impact on the specialty both regionally and internationally.

4